Search | IOVS | ARVO Journals

Showing 1 – 20 of 62

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): post-hoc analysis of injection intensive (I-I) requirement for patients in the ARIES study

Sebastian Wolf; Frank G Holz; Philip Hykin; Edoardo Midena; Eric H Souied; George Lambrou; Tobias Machewitz; Helmut Allmeier; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):423.

ARVO Annual Meeting Abstract June 2021

Association between visual acuity and intraretinal (IRF) or subretinal (SRF) fluid in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): a post-hoc analysis of the ARIES study

Varun Chaudhary; Frank G Holz; Philip Hykin; Edoardo Midena; Eric H Souied; Sebastian Wolf; Tobias Machewitz; George Lambrou; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):341.

ARVO Annual Meeting Abstract June 2020

Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study

Eric H Souied; Frank G. Holz; Philip G Hykin; Edoardo Midena; Sebastian Wolf; Helmut Allmeier; Paul Mitchell

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4210.

ARVO Annual Meeting Abstract June 2020

Comparison of treat-and-extend (T&E) dosing regimens and visual outcomes in the ARIES and ALTAIR studies of intravitreal aflibercept (IVT-AFL) in neovascular age-related macular degeneration (nAMD)

Paul Mitchell; Frank G. Holz; Philip G Hykin; Edoardo Midena; Annabelle A Okada; Eric H Souied; Kanji Takahashi; Sebastian Wolf; Helmut Allmeier; George Lambrou; Thomas Schmelter; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4219.

ARVO Annual Meeting Abstract July 2019

Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.

Paul Mitchell; Eric H Souied; Edoardo Midena; Frank G Holz; Philip G Hykin; Sebastian Wolf; Helmut Allmeier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):117.

ARVO Annual Meeting Abstract July 2019

Relative contributions of imaging markers of poor visual acuity in retinal vascular diseases.

Piyali Sen; Joan Nunez Do Rio; Manjula Nugawela; Ahmed M Hagag; Philip G Hykin; Akanksha Bagchi; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1888.

ARVO Annual Meeting Abstract July 2019

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Sandra Halim; Amy A Kirkwood; Tunde Peto; Usha Chakravarthy; Jayashree Ramu; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6555.

Retina May 2019

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

PDF

Luke Nicholson; Clara Vazquez-Alfageme; Philip G. Hykin; James W. Bainbridge; Sobha Sivaprasad
TAGS: alveolar ventilation function, cell respiration, oximetry, retinal vascular disorders, retinal vessels
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2083-2087. https://doi.org/10.1167/iovs.18-24917

Retina August 2018

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

PDF

Luke Nicholson; Roxanne Crosby-Nwaobi; Joana C. Vasconcelos; A. Toby Prevost; Jayashree Ramu; Amy Riddell; James W. Bainbridge; Philip G. Hykin; Sobha Sivaprasad
TAGS: aflibercept, panretinal photocoagulation, proliferative diabetic retinopathy, eye, oximetry
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4277-4284. https://doi.org/10.1167/iovs.17-23509

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569.

ARVO Annual Meeting Abstract June 2017

Retinal morphology and vessel oxygen saturation in normal and diabetic patients

Adam M Dubis; Luke Nicholson; Roxanne Crosby-Nwaobi; Phil Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3033.

ARVO Annual Meeting Abstract June 2017

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Maria Eleftheriadou; Maria K Gemenetzi; Sobha Sivaprasad; Philip G Hykin; Robin Hamilton; Adnan Tufail; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):874.

ARVO Annual Meeting Abstract June 2017

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Panagiotis Vasilopoulos; Andrew R Webster; Catherine A Egan; Hemal Mehta; Philip G Hykin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4639.

ARVO Annual Meeting Abstract June 2017

The distribution of macular pigment in different macular diseases

Roy Schwartz; Roxanne Crosby-Nwaobi; Adam M Dubis; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4818.

ARVO Annual Meeting Abstract September 2016

Changes in Disorganization of Retinal Inner Layers (DRIL) Predict Retinal Sensitivity in Eyes with Diabetic Macular Edema

Timothy Peiris; Oliver Comyn; Luke Nicholson; Amanda Delacruz; Migil Ledesma; Philip Hykin; Sobha Sivaprasad; Paolo Sandico Silva; Lloyd Paul Aiello; Jennifer K Sun

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Central serous chorioretinopathy in women

Priyanka Sanghi; Marta Zola; Deepthy Menon; Namritha Patrao; Jayashree Ramu; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2157.

ARVO Annual Meeting Abstract September 2016

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Maria Eleftheriadou; Clara Vazquez-Alfageme; Luke Nicholson; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3342.

ARVO Annual Meeting Abstract September 2016

Efficacy of Aflibercept in Treatment-naïve Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes

Maria Eleftheriadou; Clara Vazquez-Alfageme; Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3355.

ARVO Annual Meeting Abstract September 2016

Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months.

Marta Zola; Priyanka Sanghi; Namritha Patrao; Deepthy Menon; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3398.

ARVO Annual Meeting Abstract September 2016

Retinal non-perfusion in the posterior pole determines risk of neovascularisation in central retina vein occlusion

Luke Nicholson; Clara Vazquez-Alfageme; Namritha Valerie Patrao; Ioanna Triantafyllopoulou; Philip Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): post-hoc analysis of injection intensive (I-I) requirement for patients in the ARIES study

Association between visual acuity and intraretinal (IRF) or subretinal (SRF) fluid in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E): a post-hoc analysis of the ARIES study

Efficacy of Intravitreal Aflibercept Treat-and-Extend Regimen Over 2 Years for Neovascular Age-Related Macular Degeneration: ARIES Study

Comparison of treat-and-extend (T&E) dosing regimens and visual outcomes in the ARIES and ALTAIR studies of intravitreal aflibercept (IVT-AFL) in neovascular age-related macular degeneration (nAMD)

Efficacy of Intravitreal Aflibercept Administered using Treat-and-Extend Regimen over 2 Years in Patients with Neovascular Age-Related Macular Degeneration: 1-Year ARIES Results.

Relative contributions of imaging markers of poor visual acuity in retinal vascular diseases.

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

Retinal morphology and vessel oxygen saturation in normal and diabetic patients

Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular Degeneration

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

The distribution of macular pigment in different macular diseases

Changes in Disorganization of Retinal Inner Layers (DRIL) Predict Retinal Sensitivity in Eyes with Diabetic Macular Edema

Central serous chorioretinopathy in women

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

Efficacy of Aflibercept in Treatment-naïve Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes

Evolution of Short-wavelength Autofluorescence changes in Central Serous Chorioretinopathy over 12 months.

Retinal non-perfusion in the posterior pole determines risk of neovascularisation in central retina vein occlusion

To View More...

You must be signed into an individual account to use this feature.